as Borrower - and - BANK OF MONTREAL CIT FINANCIAL LTD. EXPORT DEVELOPMENT CANADA and LAURENTIAN BANK OF CANADA as Lenders - and - BANK OF MONTREAL and CIT GROUP SECURITIES (CANADA) INC. as Co-Lead Arrangers - and - BANK OF MONTREAL, as Administrative...Credit Agreement • September 22nd, 2014 • Merus Labs International Inc. • Pharmaceutical preparations • British Columbia
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
ASSET PURCHASE AGREEMENT between NOVARTIS AG NOVARTIS PHARMA AG AND MERUS LABS LUXCO SARL MERUS LABS INTERNATIONAL INC.Asset Purchase Agreement • September 22nd, 2014 • Merus Labs International Inc. • Pharmaceutical preparations
This ASSET PURCHASE AGREEMENT (“Agreement”) is made as of this 8th day of September, 2014 (“Closing Date”), by and between Novartis AG, a company organized under the laws of Switzerland and Novartis Pharma AG, a company organized under the laws of Switzerland, both located at Lichtstrasse 35, 4056 Basel, Switzerland (collectively, referred to as “Novartis”) and Merus Labs Luxco SARL, a company organized under the laws of Luxembourg, located at 26-28, rue Edward Steichen, L-2540 Luxembourg (“Purchaser”) and Merus Labs International Inc., a company organized under the laws of Canada, 100 Wellington Street West, Suite 2110, P.o. Box 151, Toronto, Ontario, M5K 1H1 Canada (“Merus”). Novartis, Purchaser and Merus are each referred to individually as a “Party” and together as the “Parties.”
